Vimarsana
Biggest News Aggregation in the World

Elizabeth Ling News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Elizabeth Ling. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Elizabeth Ling Today - Breaking & Trending Today

Louisiana may reclassify drugs used in abortion as controlled dangerous substances - Vimarsana News

Louisiana may reclassify drugs used in abortion as controlled dangerous substances

Louisiana could be the first state to regulate mifepristone and misoprostol in the same way as some narcotics and stimulants. Opponents predict harmful delays in miscarriage and other lawful uses.

Source: kpbs.org
Louisiana may reclassify drugs used in abortion as controlled dangerous substances - Vimarsana News

Louisiana may reclassify drugs used in abortion as controlled dangerous substances

Louisiana could be the first state to regulate mifepristone and misoprostol in the same way as some narcotics and stimulants. Opponents predict harmful delays in miscarriage and other lawful uses.

Source: wjct.org
In Louisiana, drugs for medication abortion could become controlled substances : Shots - Vimarsana News

In Louisiana, drugs for medication abortion could become controlled substances : Shots

Louisiana could be the first state to regulate mifepristone and misoprostol in the same way as some narcotics and stimulants. Opponents predict harmful delays in miscarriage and other lawful uses.

Source: npr.org
Louisiana Lawmakers Move to Criminalize Possession of Abortion Pills - Vimarsana News

Louisiana Lawmakers Move to Criminalize Possession of Abortion Pills

“This was not on anyone’s radar at all — it feels very sneaky,” says one OB-GYN.

Source: yahoo.com
Fear and confusion over abortion access persists as SCOTUS takes its first post-Dobbs case - Vimarsana News

Fear and confusion over abortion access persists as SCOTUS takes its first post-Dobbs case

The U.S. Supreme Court accepted a case last week challenging the FDA's 20-year approval of the abortion drug mifepristone. Fear and confusion persist among abortion rights advocates as the court is poised to make another major decision in 2024.